Neuromyelitis optica (NMO) is an inflammatory disease characterized by NMO immunoglobulin IgG (NMO-IgG), which is primarily considered to be an AQP4-specific antibody in NMO serum (Wingerchuk et al., 2015). This evidence concerns the gene AQP4 and neuromyelitis optica.